These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1006 related items for PubMed ID: 23900046

  • 21. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD, Kirtane AJ, Brodie BR, Witzenbichler B, Litherland C, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Gurbel PA, Mehran R, Généreux P, Ben-Yehuda O, Simonton CA, Stone GW, ADAPT-DES Investigators.
    JACC Cardiovasc Interv; 2017 Aug 28; 10(16):1607-1617. PubMed ID: 28780034
    [Abstract] [Full Text] [Related]

  • 22. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW, Lee SP, Park KW, Lee HY, Kang HJ, Koo BK, Cho YS, Youn TJ, Chae IH, Choi DJ, Rha SW, Bae JH, Kwon TG, Bae JW, Cho MC, Kim HS.
    J Am Coll Cardiol; 2011 Jan 18; 57(3):280-9. PubMed ID: 21232664
    [Abstract] [Full Text] [Related]

  • 23. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID, Colombo A.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1047-54. PubMed ID: 19626692
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial.
    Helft G, Le Feuvre C, Georges JL, Carrie D, Leclercq F, Eltchaninoff H, Furber A, Prunier F, Sebagh L, Cattan S, Cayla G, Vicaut E, Metzger JP.
    Trials; 2013 Feb 21; 14():56. PubMed ID: 23433461
    [Abstract] [Full Text] [Related]

  • 25. [Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation].
    Komiya R, Kamintani K, Kubo E, Hattori M, Kataoka H, Iwase Y, Miyoshi H, Minami M, Kato S, Arai R, Yoshida H.
    Masui; 2014 Jun 21; 63(6):629-35. PubMed ID: 24979851
    [Abstract] [Full Text] [Related]

  • 26. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
    Lee SW, Park SW, Yun SC, Kim YH, Park DW, Kim WJ, Lee JY, Lee CW, Hong MK, Kim JJ, Park SJ.
    Am Heart J; 2010 Feb 21; 159(2):284-291.e1. PubMed ID: 20152228
    [Abstract] [Full Text] [Related]

  • 27. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V, Cuisset T, Chenu P, Vrolix M, Martinez C, Dens J, Gach O, Boland J, Claeys MJ, Magne J, Barbato E, Wijns W.
    EuroIntervention; 2014 Jun 21; 10(2):204-11. PubMed ID: 24952058
    [Abstract] [Full Text] [Related]

  • 28. Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation.
    Rinfret S, Rodés-Cabau J, Bagur R, Déry JP, Dorais M, Larose E, Barbeau G, Gleeton O, Nguyen CM, Noël B, Proulx G, Roy L, Taillon I, De Larochellière R, Bertrand OF, EASY-IMPACT Investigators.
    Heart; 2013 Apr 21; 99(8):562-9. PubMed ID: 23434769
    [Abstract] [Full Text] [Related]

  • 29. A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.
    Lee H, Koo BK, Park KW, Shin ES, Lim SW, Rha SW, Bae JW, Jeon DW, Oh SK, Hur SH, Kim BS, Lee JH, Park TH, Lee NH, Kim HS, HOST-EXAM investigators.
    Am Heart J; 2017 Mar 21; 185():17-25. PubMed ID: 28267471
    [Abstract] [Full Text] [Related]

  • 30. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
    Stefanescu Schmidt AC, Kereiakes DJ, Cutlip DE, Yeh RW, D'Agostino RB, Massaro JM, Hsieh WH, Mauri L, DAPT Investigators.
    Circulation; 2017 May 02; 135(18):1720-1732. PubMed ID: 28228427
    [Abstract] [Full Text] [Related]

  • 31. Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry.
    Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Kimura T.
    Cardiovasc Interv Ther; 2013 Apr 02; 28(2):162-9. PubMed ID: 23233418
    [Abstract] [Full Text] [Related]

  • 32. Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration.
    Alshawabkeh LI, Prasad A, Lenkovsky F, Makary LF, Kandil ES, Weideman RA, Kelly KC, Rangan BV, Banerjee S, Brilakis ES.
    EuroIntervention; 2013 Jun 22; 9(2):204-11. PubMed ID: 23454910
    [Abstract] [Full Text] [Related]

  • 33. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
    Jin HY, Yang TH, Kim DI, Chung SR, Seo JS, Jang JS, Kim DK, Kim DK, Kim KH, Seol SH, Nam CW, Hur SH, Kim W, Park JS, Kim YJ, Kim DS.
    Int J Cardiol; 2013 Sep 01; 167(5):1877-81. PubMed ID: 22682702
    [Abstract] [Full Text] [Related]

  • 34. Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.
    Mrdovic I, Savic L, Krljanac G, Asanin M, Cvetinovic N, Brdar N, Stojanovic M, Djuricic N, Stankovic S, Marinkovic J, Perunicic J.
    J Interv Cardiol; 2013 Jun 01; 26(3):221-7. PubMed ID: 23373620
    [Abstract] [Full Text] [Related]

  • 35. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P, Bonello L, Torguson R, Okabe T, Pinto Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2009 Mar 15; 103(6):801-5. PubMed ID: 19268735
    [Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.
    Jiang M, You JHS.
    Clin Cardiol; 2017 Oct 15; 40(10):789-796. PubMed ID: 28683175
    [Abstract] [Full Text] [Related]

  • 37. Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.
    Manchuelle A, Delhaye C, Schurtz G, Sudre A, Hurt C, Bonello L, Puymirat E, Bauters C, Lemesle G.
    Arch Cardiovasc Dis; 2015 Apr 15; 108(4):235-43. PubMed ID: 25682548
    [Abstract] [Full Text] [Related]

  • 38. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.
    Lee CW, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Han S, Lee SG, Seong IW, Rha SW, Jeong MH, Lim DS, Yoon JH, Hur SH, Choi YS, Yang JY, Lee NH, Kim HS, Lee BK, Kim KS, Lee SU, Chae JK, Cheong SS, Suh IW, Park HS, Nah DY, Jeon DS, Seung KB, Lee K, Jang JS, Park SJ.
    Circulation; 2014 Jan 21; 129(3):304-12. PubMed ID: 24097439
    [Abstract] [Full Text] [Related]

  • 39. Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis.
    Piccolo R, Feres F, Abizaid A, Gilard M, Morice MC, Hong MK, Kim HS, Colombo A, Bhatt DL, Palmerini T, Stone GW, Windecker S, Valgimigli M.
    JACC Cardiovasc Interv; 2017 Aug 28; 10(16):1621-1630. PubMed ID: 28838471
    [Abstract] [Full Text] [Related]

  • 40. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
    Pandit A, Giri S, Hakim FA, Fortuin FD.
    Catheter Cardiovasc Interv; 2015 Jan 01; 85(1):34-40. PubMed ID: 24753084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.